Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nutex Health (NUTX) Non-Current Debt (2016 - 2025)

Nutex Health's Non-Current Debt history spans 11 years, with the latest figure at $29.2 million for Q4 2025.

  • For Q4 2025, Non-Current Debt rose 29.86% year-over-year to $29.2 million; the TTM value through Dec 2025 reached $29.2 million, up 29.86%, while the annual FY2025 figure was $29.2 million, 29.86% up from the prior year.
  • Non-Current Debt for Q4 2025 was $29.2 million at Nutex Health, up from $25.6 million in the prior quarter.
  • Across five years, Non-Current Debt topped out at $78.8 million in Q4 2021 and bottomed at $128176.0 in Q1 2021.
  • The 5-year median for Non-Current Debt is $22.5 million (2024), against an average of $21.5 million.
  • The largest annual shift saw Non-Current Debt skyrocketed 52447.99% in 2021 before it crashed 70.76% in 2022.
  • A 5-year view of Non-Current Debt shows it stood at $78.8 million in 2021, then plummeted by 70.76% to $23.1 million in 2022, then grew by 14.16% to $26.3 million in 2023, then fell by 14.63% to $22.5 million in 2024, then rose by 29.86% to $29.2 million in 2025.
  • Per Business Quant, the three most recent readings for NUTX's Non-Current Debt are $29.2 million (Q4 2025), $25.6 million (Q3 2025), and $20.5 million (Q2 2025).